The recent challenges in global chains have highlighted the importance of securing essential medications like Ivermectin. Relying on overseas manufacturers exposes nations to potential vulnerabilities, including shipping delays, expense fluctuations, and even trade threats. Moving towards domestic production of Ivermectin offers a multitude of adva